Santini P, Pola R. Letter by Santini and Pola Regarding Article, "Rivaroxaban for 18 Months versus 6
Months in Patients With Cancer and Acute Low-Risk Pulmonary Embolism: An
Open-Label, Multicenter, Randomized Clinical Trial (ONCO PE Trial)". Circulation 2025;152:e89.
PMID: 40920837
![]() |
![]() |
![]() |